Correlation Between Krystal Biotech and Adial Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Krystal Biotech and Adial Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Krystal Biotech and Adial Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Krystal Biotech and Adial Pharmaceuticals WT, you can compare the effects of market volatilities on Krystal Biotech and Adial Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Krystal Biotech with a short position of Adial Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Krystal Biotech and Adial Pharmaceuticals.

Diversification Opportunities for Krystal Biotech and Adial Pharmaceuticals

0.43
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Krystal and Adial is 0.43. Overlapping area represents the amount of risk that can be diversified away by holding Krystal Biotech and Adial Pharmaceuticals WT in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Adial Pharmaceuticals and Krystal Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Krystal Biotech are associated (or correlated) with Adial Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Adial Pharmaceuticals has no effect on the direction of Krystal Biotech i.e., Krystal Biotech and Adial Pharmaceuticals go up and down completely randomly.

Pair Corralation between Krystal Biotech and Adial Pharmaceuticals

Given the investment horizon of 90 days Krystal Biotech is expected to generate 29.63 times less return on investment than Adial Pharmaceuticals. But when comparing it to its historical volatility, Krystal Biotech is 13.15 times less risky than Adial Pharmaceuticals. It trades about 0.07 of its potential returns per unit of risk. Adial Pharmaceuticals WT is currently generating about 0.17 of returns per unit of risk over similar time horizon. If you would invest  1.75  in Adial Pharmaceuticals WT on August 29, 2024 and sell it today you would lose (1.14) from holding Adial Pharmaceuticals WT or give up 65.14% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy8.91%
ValuesDaily Returns

Krystal Biotech  vs.  Adial Pharmaceuticals WT

 Performance 
       Timeline  
Krystal Biotech 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Krystal Biotech are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Krystal Biotech is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.
Adial Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Adial Pharmaceuticals WT has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable essential indicators, Adial Pharmaceuticals is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Krystal Biotech and Adial Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Krystal Biotech and Adial Pharmaceuticals

The main advantage of trading using opposite Krystal Biotech and Adial Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Krystal Biotech position performs unexpectedly, Adial Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adial Pharmaceuticals will offset losses from the drop in Adial Pharmaceuticals' long position.
The idea behind Krystal Biotech and Adial Pharmaceuticals WT pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Complementary Tools

Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios